Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Sumitomo Pharma America Inc
March 12, 2026
Sumitomo Pharma America Inc
Orphan Drug Designation
treatment of retinitis pigmentosa
Disease Area:
Rare Diseases
Source
Scroll to Top